Provided by Tiger Trade Technology Pte. Ltd.

CMS Energy Corp

78.08
+1.031.34%
Volume:1.24M
Turnover:96.89M
Market Cap:23.93B
PE:22.15
High:78.31
Open:77.24
Low:77.10
Close:77.05
52wk High:78.31
52wk Low:67.71
Shares:306.42M
Float Shares:302.00M
Volume Ratio:0.55
T/O Rate:0.41%
Dividend:2.17
Dividend Rate:2.78%
EPS(TTM):3.52
EPS(LYR):3.52
ROE:10.86%
ROA:3.15%
PB:2.68
PE(LYR):22.15

Loading ...

CMS Energy Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Dec 17, 2025

Scotiabank Adjusts Price Target on CMS Energy to $87 From $81, Maintains Sector Outperform Rating

MT Newswires Live
·
Dec 16, 2025

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

GlobeNewswire
·
Dec 16, 2025

Aspire Announces Major Australia, EU and US Regulatory Milestones, Marking a New Chapter in Its Global Expansion

prnewswire
·
Dec 16, 2025

MetaComp and Stable Join Forces to Redefine Cross-Border Payments with Stablecoins

prnewswire
·
Dec 16, 2025

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China

GlobeNewswire
·
Dec 15, 2025

Trump's Potential Cannabis Reclassification Sparks Surge in Marijuana Stocks

Stock News
·
Dec 12, 2025

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

GlobeNewswire
·
Dec 11, 2025

Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

GlobeNewswire
·
Dec 09, 2025

Your Medicare Advantage benefits are about to expire. How to get the most of the extras you've already paid for.

Dow Jones
·
Dec 05, 2025

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

Benzinga_recent_news
·
Dec 04, 2025

Use them or lose them: Time is running out to use your Medicare Advantage benefits

Dow Jones
·
Dec 04, 2025

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

GlobeNewswire
·
Dec 03, 2025

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

GlobeNewswire
·
Dec 03, 2025

Expanded Credit Lines Could Reshape CMS Energy’s (CMS) Ability to Fund Grid and Renewable Investments

Simply Wall St.
·
Nov 28, 2025

U.S. Medicare Conducts First Large-Scale Drug Price Negotiation: 15 Drugs See Average 44% Price Cut

Deep News
·
Nov 27, 2025

CMS Unveils 2027 Rule To Refocus Medicare Advantage On Outcomes

Benzinga_recent_news
·
Nov 26, 2025

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

GlobeNewswire
·
Nov 26, 2025

Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%

MT Newswires Live
·
Nov 26, 2025

Proteomics International Secures CMS Reimbursement for PromarkerD Test

TIPRANKS
·
Nov 26, 2025